astilbin has been researched along with Infarction, Middle Cerebral Artery in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Y; Wang, R; Xue, L; Yang, Y; Zhi, F | 1 |
1 other study(ies) available for astilbin and Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Astilbin protects against cerebral ischaemia/reperfusion injury by inhibiting cellular apoptosis and ROS-NLRP3 inflammasome axis activation.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Flavonols; Infarction, Middle Cerebral Artery; Inflammasomes; Male; Mitogen-Activated Protein Kinases; Neuroprotective Agents; NLR Family, Pyrin Domain-Containing 3 Protein; PC12 Cells; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Reperfusion Injury | 2020 |